WisdomTree (WETF) Adopts Poison Pill Following 'Rapid Accumulation' of Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/21/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Tesla acquires AI hardware company for up to $2 billion in stock
WisdomTree Adopts Limited Duration Stockholder Rights Plan
March 14, 2022 5:30 AM EDTStockholders to Vote on Rights Plan at 2022 Annual Meeting
NEW YORK, March 14, 2022 (GLOBE NEWSWIRE) -- WisdomTree Investments, Inc. (WisdomTree or the Company) (NASDAQ: WETF), an exchange-traded fund (ETF) and exchange-traded product (ETP) sponsor and asset manager, today announced that its Board of Directors (the Board) adopted a limited duration stockholder rights plan (the rights plan).
The Board adopted the rights plan in response to the recent rapid accumulations of significant portions of WisdomTree outstanding common stock. It is intended to protect WisdomTree and its stockholders from efforts by a single stockholder or group of... More
